| BACHEM N -B- | 375,00 / -0,79% |
| 日期/時間 | 19.01. / 16:55 |
| 漲跌。 / 漲跌。(%) | -3,00 / -0,79% |
| Bid | 374,50 / 56 |
| Ask | 375,00 / 29 |
| 打開 | 372,50 |
| 過往收市 | 378,00 |
| 高 | 378,00 |
| 低 | 361,00 |
| 成交量 [CHF] | 7.860.734,00 |
| 成交量 [Units] | 21.321 |
| Price fixings | 731 |
| ISIN | CH0012530207 |
| 符號 | BANB |
| 交易所 | SIX Swiss Exchange |
| 類型 | 股票 |
| 交易所 | 最後的 | 成交量 | |
|---|---|---|---|
| SIX Swiss Ex.. | 375,00 |  |
21.321 |
| London Inter.. | 376,50 | |
170 |
| Lang & Schwa.. | 347,00 | |
|
| Nasdaq Other.. | 418,0000 | 48 | |
| Cboe Europe .. | 129,20 | 126 | |
| Cboe Europe .. | 128,80 | 58 | |
| Turquoise | 128,80 | |
13 |
| Frankfurt | 115,0000 | 0 | |
| Berlin | 116,20 | 0 | |
| München | 114,80 | 0 | |
| Hamburg | 114,80 | 0 | |
| EUREX | Options | ||
新聞
- Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome
14.05.2020 / 07:00 - GlobeNewswire - Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
04.05.2020 / 14:30 - GlobeNewswire - Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Trial
28.04.2020 / 15:24 - GlobeNewswire - Vaccine Contract Manufacturing Market, 2030 - Market is Anticipated to Generate Revenues Worth USD 100 Billion by 2025
04.10.2019 / 10:05 - GlobeNewswire - Global Pharmaceutical Contract Manufacturing Market 2018-2025 - Patent Expiration Of Small Molecules Drugs & Advanced Technologies In API And FDF Manufacturing
26.03.2019 / 10:57 - GlobeNewswire